Darolutamide
Wikipage redirect
ATC code L02Androgen deprivation therapyApalutamideBAY-1841788BicalutamideC19H19ClN6O2Comparison of bicalutamide with other antiandrogensDarramamideFeminizing hormone therapyKetodarolutamideList of antiandrogensNonsteroidalNonsteroidal antiandrogenNubeqaODM-201ODM201ODM 201Orion CorporationPeripherally selective drug
Link from a Wikipage to another Wikipage
primaryTopic
Darolutamide
has abstract
Darolutamide, sold under the b ...... and in Australia in July 2020.
@en
alternative name
Nubeqa
@en
CAS number
1297538-32-9
DrugBank
FDA UNII code
X05U0N2RCO
KEGG
MedlinePlus
PubChem
Link from a Wikipage to an external page
Wikipage page ID
47,733,699
page length (characters) of wiki page
Wikipage revision ID
1,014,120,760
Link from a Wikipage to another Wikipage
ATC prefix
L02
@en
ATC suffix
BB06
@en
bioavailability
≤30%
@en
CAS number
ChemSpiderID
38,772,320
DailyMedID
Darolutamide
@en
DrugBank
DB12941
@en
elimination half-life
excretion
Feces: 32.4%
@en
Urine: 63.4%
@en
image
@en
IUPAC name
N--5--1H-pyrazole-3-carboxamide
@en
KEGG
D11045
@en
legal AU
S4
@en
legal EU
Rx-only
@en
legal US
Rx-only
@en
licence EU
yes
@en
MedlinePlus
a619045
@en
metabolism
Dehydrogenation , glucuronidation
@en
metabolites
pregnancy AU
X
@en
pregnancy US
N
@en
protein bound
Darolutamide: 92%
@en
Ketodarolutamide: 99.8%
@en
PubChem
67,171,867
routes of administration
SMILES
C[C@@H]NCc3ccCO
@en
StdInChIKey
BLIJXOOIHRSQRB-PXYINDEMSA-N
@en
synonyms
Darramamide, ODM-201, BAY-1841788
@en
tradename
Nubeqa
@en
UNII
X05U0N2RCO
@en